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Haemodynamic 
changes after induction 
of anaesthesia with 
sevoflurane vs. propofol
ABSTRACT
Inhalation induction with sevoflurane would appear to offer several objective advantages compared to  induction with propofol. 
In our study, the hemodynamic results of sevoflurane vs. propofol induction in patients undergoing thoracotomy were studied. 
In a prospective, randomized, blinded study 24  patients were randomly allocated to one of 2 groups: sevoflurane (S) and 
propofol (P) (n=12 each). For  hemodynamic monitoring the LIDCO plus system was used. Patients in  group S were induced 
into anaesthesia with sevofluran, remifentanil and vecuronium, whereas patients in group P with propofol, remifentanil and 
vecuronium. The anaesthesia was maintained with the same agents. Hemodynamic stability was guided using a special algo-
rithm. The goal was oxygen delivery index (DO2I) > 500 mL min-1 m-2. According to the algorithm, patients received colloids 
or vasoactive drugs. Hemodynamic parameters were recorded before induction, 3 minutes after induction and 3 minutes after 
intubation and commencement of  one lung ventilation. The consumption of vasoactive drugs and colloids and the time from 
the beginning of  induction to intubation were documented. No statistically significant differences in measured hemodyna-
mic parameters, remifentanil and colloid consumption between the S and P group were found. In group P, statistically more 
ephedrine was used (S: 4.2, P:20.8, p<0.05). Patients undergoing thoracotomy induced with sevoflurane are circulatory more 
stable than those induced with propofol.
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Introduction 
According to the literature, inhalation 
induction of anaesthesia with sevo-
flurane would appear to offer several 
objective advantages over induction 
with propofol: induction with sevoflu-
rane is significantly slower compared 
to  propofol, it is associated with a 
lower incidence of apnoea, less  time 
is needed to establish spontaneous 
ventilation, induction complications are 
uncommon, and the majority of patients 
find induction with sevoflurane more 
acceptable. (1,2)
In the past, inhalation anaesthetics, 
including sevoflurane, were not consi-
dered ideal for use in  thoracic surge-
ry, since they were believed to reduce 
hypoxic pulmonary vasoconstriction, 
thereby increasing the “shunting” of 
non-oxygenated blood during one lung 
ventilation (OLV) and causing hypoxia. 
(3) This view has been refuted by seve-
ral studies. (4-6) 
During OLV, hypoxic vasoconstriction 
results in hypoxia of the lung parenchy-
ma in the non-ventilated lung. A recent 
study focusing on lung injury caused 
by OLV in pigs showed congested vas-
culature in the deflated non-ventila-
ted lung. This could be the result of 
an inflammatory response to hypoxia. 
Sevoflurane decreases  hypoxic pulmo-
nary vasoconstriction and the degree of 
hypoxic injury. (7)
Since sevoflurane has a protective 
effect on the heart, it could have a simi-
lar effect on lung tissue. Sevoflurane 
also has favourable effects on the infla-
mmatory response which is triggered 
by OLV. Due to  these properties, it is 
increasingly used in open lung surgery. 
(8-11)
The maintenance of  haemodynamic 
stability  is very important in open lung 
surgery. These are generally very com-
plex operations, performed in patients 
with  associated cardiovascular illne-
sses, in whom haemodynamic instabi-
lity is a common problem. (12) One of 
the most sensitive phases (in terms of 
haemodynamics) during an open lung 
operation is the induction of anaesthe-
sia and the beginning of one lung ven-
tilation. (13) In our study, we compared 
the haemodynamic effects of sevoflu-
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rane and propofol during this phase of 
thoracotomy. A similar comparison has 
not been performed, to our knowledge. 
Our working hypothesis was that pati-
ents anaesthetized with sevoflurane, 
would have greater circulatory stability 
than patients anaesthetized with pro-
pofol.
Patients and methods
This study was designed as a pilot 
study to be conducted in prepara-
tion for a larger study. The  protocol 
was approved by the  National Medical 
Ethics Committee of the Republic of 
Slovenia. Twenty-four patients accord-
ing to the  American Society of Anaes-
thesiologists classification (ASA) II-III 
patients admitted for an elective ante-
rolateral thoracotomy during a period 
of 2 months were enrolled after giving 
written informed consent.   We chose 
this time interval and includeAd as 
many patients as were gathered dur-
ing this period  because we had no 
idea of the values  for power analysis. 
Each patient was randomly allocated 
to one of two induction groups using 
a computer-generated sequence with 
sealed envelopes. Patients with a histo-
ry of malignant hyperthermia or adverse 
reaction to inhalation anaesthetics or 
propofol were excluded from the study. 
Patients with severe chronic obstructive 
pulmonary disease  (Forced expiratory 
Volume in first second (FEV1) <40% 
of predicted value), anaemia (Hb<100 
g L-1) or contraindications for use of a 
LiDCO haemodynamic monitor were 
also excluded. 
One hour before surgery, all patients 
were premedicated with 5 mg of oral 
diazepam (Apaurin, Krka, d.d., Slov-
enia). An intravenous catheter, a central 
venous catheter, and a radial artery 
catheter were introduced into the fore-
arm opposite  the side of surgery. Arterial 
blood was withdrawn for determination 
of haemoglobin, blood gas and serum 
sodium levels needed for calibration of 
a  LiDCO Plus haemodynamic monitor 
(LiDCO, London, UK).  (14,15)
The LiDCO monitor was connected to 
the patient before induction of anae-
sthesia. (For calibration of the system, 
0.3 mL of lithium chloride was injec-
ted into the central or  the peripheral 
venous line, and the lithium concen-
tration in arterial blood was recorded 
by withdrawing blood past a lithium 
sensor attached to the  arterial line. 
Following calibration with the cardiac 
output value, the system calculated the 
beat-to-beat cardiac output (CO) by 
analyzing the arterial blood pressure 
trace. (14,15) It was calibrated accor-
ding to the manufacturer’ instructions. 
The baseline haemodynamic parame-
ters were then recorded.  
The study was carried out by two anae-
sthesiologists, one was responsible for 
induction of  general anaesthesia, and 
va, GlaxoSmithKline d.o.o., UK) was 
administered to  both groups.  When 
the bispectral index (BIS) value decre-
ased below 60%, vecuronium bromide 
0.1 mg kg-1 (Norcuron, Organon) was 
injected. 
Monitoring included continuous elec-
trocardiogram (leads II and V5), heart 
rate, invasive arterial blood pressure, 
BIS,  central venous pressure (CVP), 
pulse oximetry, end-tidal carbon dioxi-
de (ETCO2), inspired oxygen concen-
tration (FiO2), peak and plateau airway 
pressures, tidal volume, and minute 
ventilation. The following haemodyna-
mic parameters were measured by the 
LiDCO Plus system: oxygen delivery 
Figure 1. The extent of the change in DO2I, CI, SVRI, MAP and HR at the various 
points with sevoflurane (blue) and propofol (pink).
CI, cardiac index; DO2I, oxygen delivery index; HR, heart rate; MAP, mean arterial pressure; 
SVRI, systemic vascular resistance index.
the other for monitoring. The latter, who 
was unaware of the patients’ distribu-
tion between the two groups, guided 
the former, indicating when to admini-
ster additional anaesthetics, vasoactive 
drugs or fluids. 
Before induction, all patients received 
oxygen for 1 min from a clear plastic 
face mask at a flow rate of 5 L min-
1. In one group of patients, induction 
was performed with 8% sevoflurane 
(Sevorane, Abbott Laboratories d.o.o., 
Illinois, USA). In the second group, 1% 
propofol (Fresenius Kabi, Germany) 
was injected at a dose of 1.5-2.5 mg 
kg-1. Remifentanil 0.5 g kg-1 (Ulti-
index (DO2I), cardiac index (CI), stroke 
volume variation (SVV), and systemic 
vascular resistance index (SVRI).
Haemodynamic management was per-
formed using the goal-directed therapy 
approach. A  DO2I value of 500 mL 
min-1 m-2 was selected as the target 
value. (15) The primary outcome for 
oxygen delivery  was based on the ava-
ilable data as a likely optimum between 
accomplishing the desired effect and 
avoiding possible consequences  of 
a higher CO. (15)  SVV was used as 
a dynamic marker of fluid responsive-
ness to guide  haemodynamic mana-
gement. (16 ) If DO2I decreased below 
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500 ml min-1 m-2  with SVV exceeding 
10%, a colloid solution  consisting of 
6% hydroxyethyl starch 130/0.4 in 0.9% 
sodium chloride (Voluven R, Fresenius 
Kabi, Germany) was administered at 
a rate of 20 ml kg-1 h-1 until SVV fell 
below 10%. If  DO2I failed to reach 500 
ml min-1 m-2  with fluid alone, one or 
more 5 mg boluses of ephedrine hydro-
chloride (0.5% Efedrin, Central Pharma-
cy of the University Medical Centre Lju-
bljana) were administered. The same 
treatment, i.e. one or more 5 mg bolu-
ses of ephedrine hydrochloride, was 
given  if SVRI decreased below 1500 
dyn s cm-5 m2. According to Hensley 
et al, ephedrine causes  appreciable 
increases in CO, blood pressure and 
contractility, and also   slight increases 
in SVR and heart rate. (17)
One lung ventilation was performed 
via a double-lumen endobronchial 
tube (Broncho-Cath, Mallinckrodt).  A 
Cato volume cycled ventilator (Dräger, 
Lübeck, Germany) was used with the 
tidal volume  set to 8 mL kg-1 of ideal 
body weight, the inspiratory-to-expi-
ratory ratio to 1:2,  and the positive 
end-expiratory pressure to 5 cmH2O. 
Arterial haemoglobin oxygen saturation 
was maintained above 98% by admini-
stering 80-100% oxygen.  ETCO2 levels 
were kept in the range of 3 to 6 kPa 
by adjusting the tidal volume and the 
respiratory rate.
Anaesthesia was maintained with  2% 
sevoflurane  in one group of patients. In 
the second group, propofol was admi-
nistered at a rate of 100-200 g kg-1 
min-1. Both groups received remifenta-
nil at a rate  of 0.2 g kg-1 min-1.  If the 
mean arterial pressure and/or heart rate 
increased by 30%, the patient would 
receive an additional bolus of 0.5 g kg-
1of remifentanil. The depth of anaesthe-
sia was controlled by BIS monitoring. If 
the BIS value remained above 60, the 
patient would either be given an additi-
onal bolus of 0.5 mg kg-1 of propofol or 
would continue to receive  sevoflurane 
in the initial concentration (8%).
Haemodynamic parameters were recor-
ded after induction (3 min after BIS fell 
below 60  and 3 min after the patient was 
intubated and one lung ventilation was 
started. The time from the beginning 
of induction to the second  recording 
of the haemodynamic parameters, the 
consumption of colloid solutions, and 
the consumption of ephedrine were 
documented.
Statistical Analysis
The null hypothesis under test was that 
sevoflurane and propofol do not dif-
fer significantly in their haemodyna-
mic effects when used for induction 
of anaesthesia in patients undergoing 
thoracotomy. Accordingly, the primary 
outcome measure was the amount of 
supplemental ephedrine and colloids 
required to maintain the oxygen delivery 
index above 500 mL min-1 m-2. 
Statistical analysis was performed 
using a statistical software package 
San Jose, CA. The normal distributi-
on of data was first evaluated with the 
Kolmogorov-Smirnov test. Continuo-
us variables were then analyzed using 
Student’s t-test or the  Mann-Whitney 
u-test depending on data distribution. 
Categorical variables were analyzed 
with the contingency table analysis and 
Fisher’s exact test. A P value  5% 
was considered  significant. Continu-
ous variables were presented as mean 
(±SD) or median (range), while cate-
gorical variables were presented as 
count (%). 
Results
There were no significant differences 
in age, weight, height, gender, ASA 
physical status distribution, or duration 
of induction between the two groups 
(table 1).
The baseline haemodynamic data 
(DOI2, CI, SV, SVV, SVRI, Mean arterial 
pressure (MAP), heart rate (HR), CVP) 
also did not differ significantly between 
the two groups, as evident from table 2. 
The CI, MAP, HR and SVRI values 
recorded after induction and clamping 
of one lumen of the Carlens tube are 
presented  in table 3. DO2I was main-
tained above 500 mL min-1 m-2  in all 
patients, and its values did not differ 
significantly  between the two groups. 
However, the amount of ephedrine nee-
ded to maintain DO2I above the target 
value was significantly greater in the 
propofol group (20.8±5.2 mg) compa-






          p
Age (year) 52.7±14.6 60.9±9.4 0.16
Weight (kg) 77.6±13.5
81.9±15.2 0.49
Height  (cm) 174.3±9.5 172.8±9.5 0.73
Sex (f/m) 5/7 4/8 x
ASA physical status 
1/2/3/4 (n)
0/4/8 0/5/7 x
Duration of induction 
(min) 
6.95±2.5 7.1±2.3 0.89
ASA, American Society of Anaesthesiologists.
Values are means ± SD or count. There were no statistically significant differences observed 
between groups.
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red to the sevoflurane group (4.2±1.3 
mg) (P = 0.03). The amount of collo-
ids infused did not differ significantly 
between the two groups (289 mL vs. 
189 mL, respectively, P = 0.19). 
No patients needed additional boluses 
of remifentanil. The BIS values showed 
no differences in depth of anaesthesia 
between the two groups  (table 4).
In figure 1 you can see the extent of the 
change in DO2I, CI, SVRI, MAP and HR 
at the various points with sevoflurane 
(blue) and propofol (pink).
Discussion
Our study showed that patients anae-
sthetized with sevoflurane were  hae-
modynamically more stable than pati-
ents given propofol, since the amount 
of ephedrine needed to maintain hae-
modynamic stability was lower in the 
sevoflurane group  than in the propofol 
group (table 3). 
A similar conclusion was reached by 
Thwaites et al. who found that the mean 
arterial pressure was more stable when 
anaesthesia was induced with sevoflu-
rane as compared to propofol. (1)
Unlike Thwaites et al. who concentra-
ted on MAP, we also measured seve-
ral other haemodynamic parameters, 
which enabled us to examine more spe-
cifically the influence of sevoflurane on 
haemodynamics.
Table 2: Baseline haemodynamic data.
Sevoflurane 
group
Propofol group           p
DO2I 
(mL min-1 m-2) 664±206 699±177 0.53
CI 
(L min-1 m-2) 3.2±2.06 3.7±1.77 0.23
SVRI
(dyn s cm-5 m2) 2550±886 2120±797 0.27
MAP 
(mmHg) 103±17 99±12 0.51
HR 
(min-1) 73±21 80±9 0.38
CI, cardiac index; DO2I, oxygen delivery index; HR, heart rate; MAP, mean arterial pressure; 
SVRI, systemic vascular resistance index.
Values are means ± SD. There were no statistically significant differences observed between 
groups.
Our study was performed on patients 
undergoing open lung surgery. As we 
know, lung disease requiring thoraco-
tomy is very often associated with other 
diseases, especially with cardiovascular 
disorders. An open lung operation is a 
complicated procedure, which often 
results in circulatory instability with con-
sequent tissue hypoperfusion. (18) One 
lung ventilation,  carried out during these 
operations, frequently leads to serious 
complications. It would thus be advan-
tageous to use  anaesthetics that have 
the least effect on haemodynamics.
In our study, haemodynamic parame-
ters were measured after the induction 
of anaesthesia and at the beginning of 
one lung ventilation, when  haemodyna-
mic instability  is especially frequent. 
(18) After induction, the haemodynamic 
values in both groups of patients decre-
ased by about 30% but  remained within 
the normal range. However, the patients 
anaesthetized with propofol required 
substantially more ephedrine to mainta-
in the haemodynamic parameters within 
the normal range and thus ensure nor-
mal tissue perfusion. This means that 
the patients in the propofol group were 
haemodynamically less stable than the 
patients in the sevoflurane group.
The cardiovascular effects of sevoflura-
ne are similar to those of isoflurane. (19-
21) Sevoflurane causes a dose-depen-
dent depression of right ventricular fun-
ction. (22) Propofol is believed  to cause 
a reduction in systolic and diastolic arteri-
al pressures by lowering  SVRI and after-
load. (23) Some studies on people and 
animals showed that it had no influence 
on CI, (23-25) while in others it caused a 
reduction in CI. (26,27) Its haemodyna-
mic effects  depend on the speed of 
administration and on  associated car-
diovascular diseases. (26,28). Filipovic 
et al. observed that sevoflurane had no 
effect on left ventricular relaxation, while 
propofol influenced it to a certain extent. 
However, neither sevoflurane nor pro-
pofol caused a clinical diastolic dysfun-
ction. (29)  Fredman et al. established 
that although the mean arterial pressure 
values were similar after induction with 
sevoflurane or propofol, the use of sevo-
flurane was associated with consistently 
lower heart rate. (30) Similar conclusions 
about the effects of sevoflurane on  heart 
rate and mean arterial pressure were 
reached by Ebert et al. (20)
Ephedrine, used in this study, has a 
non-selective stimulating effect on alpha 
and beta adrenergic receptors. By using 
more specific substances,  like nora-
drenalin and dobutamine, and ensuring 
their targeted administration while chan-
ging individual haemodynamic parame-
ters, we could have confirmed that pro-
pofol was more potent in reducing CI or 
SVRI. However, these substances may 
be administered only in the form of infu-
sion at very low doses. Consequently, it 
would have been difficult to titrate  their 
effects during the short time that was 
available in this study. We will be able to 
use them in our further  research when 
we compare the haemodynamic effects 
of sevoflurane and propofol throughout 
the duration of thoracotomy. 
In the present study, bispectral index 
was measured in all patients to  prevent 
achieving better circulatory stability at 
the expense of awareness and pain. 
Blood pressure and heart rate were 
also monitored. The BIS values ranged 
between 40 and 60, while BP and HR 
did not increase by more than 30% 
above the baseline value. None of the 
patients needed an additional bolus of 
analgesics. The rate of  infusion of remi-
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Table 3. Haemodynamic parameters measured after induction and after tube 
clamping. 


























77 ± 9 78 ± 10 0.82
SVRI after 
induction
(dyn s cm-5 m2)
2816 ± 771 2437 ± 898 0.31
SVRI after 
clamping
(dyn s cm-5 m2)
2722 ± 725 2382 ± 898 0.35
Ephedrin given
(mg) 4.2±1.3 20.8±5.2 0.03
CI, cardiac index; HR, heart rate; MAP, mean arterial pressure; SVRI, systemic vascular 
resistance index.
Values are means ± SD. There were no statistically significant differences observed between 
groups.
Table 4. Bispectral index (BIS) after induction and after tube clamping.










Values are means ± SD. There were no statistically significant differences observed between 
groups
fentanil, calculated according to  body 
weight, was the same in both groups.
Until recently, the use of inhalation ana-
esthetics in lung surgery has been que-
stioned because of  the possibility of 
reversing hypoxic vasoconstriction in 
the non-ventilated lung and thus cau-
sing hypoxia. (3) Several recent studies 
have refuted this view, and sevoflurane 
has been increasingly recognized as a 
suitable anaesthetic for thoracotomy 
due to its positive effects on the cardi-
ovascular system, respiratory organs 
and inflammatory response. (8 -11)
Our study could have been improved by 
continuous  recording of haemodyna-
mic parameters throughout the induc-
tion  of anaesthesia. This would have 
enabled us to determine the minimum 
and the maximum values of the hae-
modynamic parameters  studied, and 
to examine more specifically the action 
of the two anaesthetic agents.
It would be useful to record and analyze 
the haemodynamic effects of propofol 
and sevoflurane throughout the duration 
thoracotomy, and to measure their effect 
on the inflammatory response by deter-
mining   cytokine levels in the blood. 
This study serves as a pilot study for a 
larger investigation  in which we plan to 
examine more closely the haemodyna-
mic effects and anti-inflammatory acti-
vity of sevoflurane in patients undergo-
ing thoracotomy. 
Conclusion
Our pilot study showed that sevoflurane 
is superior to propofol in terms of hae-
modynamic stability, which is evident 
from a lesser  consumption of ephedri-
ne during the induction of anaesthesia. 
However, further studies will be needed 
to evaluate the impact of sevoflurane on 
haemodynamic stability and on the infla-
mmatory response throughout the durati-
on of anaesthesia  in patients undergoing 
thoracotomy with one lung ventilation.
 57www.signavitae.com
REFERENCES
1. Thwaites A, Edmends S, Smith I. Inhalation induction with sevoflurane: a double-bind comparison with propofol. Br J Anaesth 1997;78:356–61. 
2. Patel SS, Goa KL (April 1996). Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general 
anaesthesia. Drugs  1996; 51(4):658–700.
3. Abe K, Shimizu T, Takashina M, Shiozaky H, Yoshiya Il. The effects of propofol, isoflurane, and sevoflurane on oxygenation and shunt 
fraction during one lung ventilation. A & A 1998;87:1164-9.
4. Pruszkowski O. Effects of propofolvssevoflurane on arterial oxygenation during one lung ventilation. British Journal of Anasthesia 1998:539-44.
5. Beck DH,  Doepfmer UR, Sinemus C, Bloch A, Schenk MR, Kox WJ. Effects of sevoflurane and propofol on pulmonary shunt fraction during 
one-lung ventilation for thoracic surgery. Br J Anaesth 2001;86(1):38-43.
6. Rogers SN, Benumof JL.Halothane and Isoflurane Do Not Decrease Pao2 during One-Lung Ventilation in Intravenously Anesthetized Pati-
ents. A & A 1985;64(10): 946-54.
7. Mulligan MS, Vaporciyan AA, Warner RL, Jones ML, Foreman KE, Miyasaka M, et al. Compartmentalized role for leukocytic adhesion 
molecules in lung inflammatory injury. J Immunol 1994;154:1350–63. 
8. De Conno E, Steurer MP, Wittlinger M, Zalunardo MP, Weder W, Schneiter D, et al.  Anesthetic-induced improvement of the inflammatory 
response to one lung ventilation. Anesthesiology 2009;110(6):1316-26.
9. Hofstetter C, Boost KA, Flondor M, Basagan-Mogol E, Betz C, Homann M, et al.  Anti-inflammatory effects of sevoflurane and mild hypot-
hermia in endotoxemic rats.  ActaAnaesthesiolScand 2007;51:893-9.
10. Steurer M, Schlaepfer M, Steurer M, Z’graggen BR, Booy C, Reyes L, et al. The volatile anaesthetic sevoflurane attenuates lipopolysacc-
haride-induced injury in alveolar macrophages. Clin ExpImmunol 2009;155(2):224-30.
11. Kersten JR, Brayer AP, Pagel PS, Tessmer JP, Warltier DC. Perfusion of ischemic myocardium during anesthesia with sevoflurane. Ane-
sthesiology 1994;81(4):995-1004.
12. Hill RC, Jones DR, Vance RA, Kalantarian B. Selective lung ventilation during thoracoscopy: effects of insufflations on hemodynamics. Ann 
ThoracSurg 1996;61: 945-8.
13. Ohtsuka T, Imanaka K, Endoh M, Kohno T, Nakajima J, Kotsuka Y, Takamoto S. Hemodynamic effects of carbon dioxide insufflations under 
single-lung ventilation during thoracoscopy. Ann ThoracSurg 1999;68:29-33.
14. Rhodes A, Sunderland R. Arterial pulse pressure analysis: The LiDCO. In: Pinsky MR, Payen D, editors. Functional Hemodynamic Monito-
ring. Update in Intensive Care and Emergency Medicine 42. Berlin, Heidelberg: Springer-Verlag; 2004.p. 183-92.
15. Kapoor PM, Kakani M, Chowdhury U, Choudhury M, Lakshmy, Kiran U. Early goal-directed therapy in moderate to high-risk cardiac surgery 
patients. Ann Card Anaesth 2008;11:27-34.
16. Reuter DA, Goresch T, Goepfert MSG, Wildhirt SM, Kilger E, Goetz AE. Effects of mid-line thoracotomy on the interaction between mecha-
nical ventilation and cardiac filling during cardiac surgery. BJA 2004;92(6):808-13.
17. Hensley FA, Martin DE, Gravlee GP.  A practical approach to cardiac anesthesia, 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2008.p. 43.
18. Trca S, Krska Z, Kittnar O, Mlcek M, Demes R, Danzig V, et al. Haemodynamic response to thoracoscopy and thoracotomy. Physiological 
Research 2010;59(3):1-8.
19. Malant TP, Dinardo JA, Isner RJ, Frink EJ, Golderg M, Fenster PE, et al. Cardiovascular effects of sevoflurane compared with those of 
isoflurane in volunteers. Anesthesiology 1995;83(5):918-28.
20. Ebert TJ, Harkin CP, Muzi M. Cardiovascular responses to sevoflurane: a review. A & A 1995;81(6):11-22.
21. Hikasa Y, Okuyama K, Kakuta T, Takase K, Ogasawara SS. Anesthetic potency and cardiopulmonary effects of sevoflurane in goats: 
comparison with isoflurane and halothane. Can J Vet Res 1998 October;62(4):299–306.
22. Fujita Y, Yamasaki T, Takaori M, Sekioka K. Sevofluraneanaesthesia for one lung ventilation with PEEP to the dependent lung in sheep: 
effects on right ventricular function and oxygenation. Can J Anaesth 1993;40(12):1195-200.
23. Claeys MA, Gepts E, Camu F. Haemodynamic changes during anaesthesia induced and maintained with propofol. Br J Anaesth 
1988;60(1):3-9.
24. Ilkiw JE, Pascoe PJ. Cardiovascular effects of propofol alone and in combination with ketamine for total intravenous anesthesia in cats. 
AJVR 2003;64(9):913-7.
25. Aun CST, Sung RYT, O’meara ME, Short TG, Oh TE. Cardiovascular effects of i.v. induction in children: comparison between propofol and 
thiopentone. Br J Anaesth 1993;70(6):647-53.
26. Stephan H, Conntag H, Schenk HD, Kettler D, Khambata HJ. Effects of propofol on cardiovascular dynamics, myocardial blood flow and 
myocardial metabolism in patients with coronary artery disease. Br J Anaesth 1986 Sep;58(9):969-75.¬
27. Goodchild CS, Chir B, Serrao JM. Cardiovascular effects of propofol in anaesthetized dog. Br J Anesth 1989;63:87–92.
28. Zheng D, Upton RN, Martinez AM, Grant C, Ludbrook GL. The influence of the bolus injection rate of propofol on its cardiovascular effects 
and peak blood concentration in sheep. A & A 1998;86:1109-15.
29. Filipovic M, Wang J, Michaux I, Hunziker P, Skarvan K, Seeberger MD. Effects of halothane, sevoflurane and propofol on left ventricular 
diastolic function in humans during spontaneous and mechanical ventilation. Br J Anaesth 2005;94(2):186-92.
30. Fredman B, Nathanson MH, Smith I, Wang J, Klein K, White PF. Sevoflurane for outpatient anesthesia: a comparison with propofol. A & A 
1995;81:823-8.
